Results showed that metabolic pathways had great changed in HCS1 compared with VNP20009, and HCS1 had a substantially lower invasion of tumor cells in vitro and produced extremely low cytotoxicity even at a high dose by intracellular bacteria counts and lactate dehydrogenase (LDH) assays. This evidence concerns the gene CSH1 and neoplasm.